Please use this identifier to cite or link to this item:
Title: Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
Authors: TRINDADE, MariliaVASCONCELOS, Jessica Castro deAYUB, GabrielGRUPENMACHER, Alex TreigerHUARACHI, Delma Regina GomesVITURINO, MarinaCORREA-GIANNELLA, Maria LuciaATALA, Yeelen BallesterosZANTUT-WITTMANN, Denise EngelbrechtPARISI, Maria CandidaALVES, Monica
Citation: FRONTIERS IN ENDOCRINOLOGY, v.12, article ID 585823, 8p, 2021
Abstract: Objective Diabetes can affect the eye in many ways beyond retinopathy. This study sought to evaluate ocular disease and determine any associations with peripheral neuropathy (PN) or cardiac autonomic neuropathy (CAN) in type 2 diabetes (T2D) and Charcot arthropathy (CA) patients. Design A total of 60 participants were included, 16 of whom were individuals with T2D/CA, 21 of whom were individuals with T2D who did not have CA, and 23 of whom were healthy controls. Ocular surface evaluations were performed, and cases of dry eye disease (DED) were determined using the Ocular Surface Disease Index (OSDI) questionnaire, ocular surface staining, Schirmer test, and Oculus Keratograph 5M exams. All variables were used to classify DED and ocular surface disorders such as aqueous deficiency, lipid deficiency, inflammation, and ocular surface damage. Pupillary and retinal nerve fiber measurements were added to the protocol in order to broaden the scope of the neurosensory ocular evaluation. PN and CAN were ascertained by clinical examinations involving the Neuropathy Disability Score (for PN) and Ewing's battery (for CAN). Results Most ocular variables evaluated herein differed significantly between T2D patients and controls. When the controls were respectively compared to patients with T2D and to patients with both T2D and CA, they differed substantially in terms of visual acuity (0.92 +/- 0.11, 0.73 +/- 0.27, and 0.47 +/- 0.26, p=0.001), retinal nerve fiber layer thickness (96.83 +/- 6.91, 89.25 +/- 10.44, and 80.37 +/- 11.67 mu m, p=0.03), pupillometry results (4.10 +/- 0.61, 3.48 +/- 0.88, and 2.75 +/- 0.81 mm, p=0.0001), and dry eye symptoms (9.19 +/- 11.71, 19.83 +/- 19.08, and 24.82 +/- 24.40, p=0.03). DED and ocular surface damage also differed between individuals with and without CA, and were associated with PN and CAN. Conclusion CA was found to be significantly associated with the severity of ocular findings. DED in cases of CA was also associated with PN and CAN. These findings suggest that intrinsic and complex neurosensory impairment in the eyes, peripheral sensory nerves, and the autonomic nervous system are somehow connected. Thus, a thorough ocular evaluation may be useful to highlight neurological complications and the impact of diabetes on ocular and systemic functions and structures.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - LIM/18
LIM/18 - Laboratório de Carboidratos e Radioimunoensaios

Artigos e Materiais de Revistas Científicas - ODS/03

Files in This Item:
File Description SizeFormat 
art_TRINDADE_Ocular_Manifestations_and_Neuropathy_in_Type_2_Diabetes_2021.PDFpublishedVersion (English)493.58 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.